Inrig Jula Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
12
Insider Sells Sum
$342,265.33

Insider Activity of Inrig Jula

According to the SEC Form 4 filings, Inrig Jula, being in a position of

  1. EVP, Head of R&D & CMO at Travere Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 101603 shares for $5.16M,
    over all time since 2023-01-04, has bought 0 shares, and sold 122816 shares for $5.51M.

Biography of Inrig Jula

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $5,155,13011100

Comparison of Insiders on Amount of Buys and Sells

2026-09-15SaleTravere Therapeutics, Inc.
TVTX
EVP, Head of R&D & CMO
44,674
0.0479%
$62.34$2.79M-15.55%
2026-05-06SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
311
0.0003%
$43.95$13,668+25.87%
2026-05-05SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
2,174
0.0024%
$46.65$101,417+25.7%
2026-05-04SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
20,000
0.0217%
$45.00$900,000+25.34%
2026-04-15SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
1,018
0.0015%
$42.61$43,377+36.08%
2026-04-14SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
7,215
0.0104%
$41.93$302,516+31.88%
2026-02-04SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
1,779
0.002%
$32.21$57,295+59.22%
2026-02-03SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
6,956
0.0076%
$32.12$223,427+53.44%
2026-01-06SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
445
0.0005%
$37.75$16,799+32.6%
2026-01-05SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
2,031
0.0024%
$40.18$81,606+23.8%
2025-12-24SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
15,000
0.0175%
$42.00$630,005+14.65%
2025-07-01SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
815
0.0009%
$14.65$11,940+103.81%
2025-02-12SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
2,568
0.0029%
$23.53$60,426-9.09%
2025-02-04SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
1,066
0.0012%
$20.11$21,437-0.05%
2025-02-03SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
4,207
0.0048%
$20.12$84,645+4.3%
2025-01-06SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
440
0.0005%
$18.76$8,254+9.06%
2025-01-03SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
2,066
0.0024%
$19.10$39,461+7.69%
2024-09-10SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
684
0.0009%
$12.98$8,878+37.81%
2024-09-09SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
2,191
0.0026%
$11.52$25,240+37.44%
2024-02-01SaleTravere Therapeutics, Inc.
TVTX
CHIEF MEDICAL OFFICER
2,174
0.0028%
$8.53$18,547+5.29%
Total: 24
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.